Health Canada

Health Canada's 72-Hour Rule for Foreign Recalls and Risks

By Kieran Redington, Founder of MedFortis Published 30 October 2026 ~6 min read

Most post-market rules are about what happens in the country that wrote them. One of Health Canada's is about what happens everywhere else. If a regulator abroad recalls your device, warns about a risk or suspends its authorisation, Health Canada expects to hear about it from you within 72 hours. The clock starts when you receive or become aware of the information, whichever is first, so what matters most is how quickly you find out.

The foreign risk notification rule

Amendments to Canada's Medical Devices Regulations, published in December 2020 and in force from June 2021, added a duty to report foreign risks. It applies to holders of medical device licences for Class II, III and IV devices, and to establishment licence holders who import them. Class I devices follow the older incident reporting rules instead.

The deadline is 72 hours after the licence holder receives the information or becomes aware of it, whichever happens first.

What triggers it

The rule covers actions by foreign regulatory agencies on a list that Health Canada publishes. You have to notify Health Canada about:

Check Health Canada's current list of agencies and its guidance for the exact scope. The point for planning is that an action by a major regulator elsewhere can start a Canadian clock.

Why the clock is the difficult part

If your own company issues a recall in the US, your Canadian team will usually hear about it quickly. The harder cases are the ones you didn't start: a regulator publishing a safety communication about your device type, or a distributor in another country triggering an action. Those appear on the regulator's website, and if nobody is watching it, the 72 hours can pass before anyone notices.

It's sensible to assume Health Canada may ask when the information was first published, not only when your team saw it. A process that relies on someone checking several regulators' websites when they have time is hard to defend.

Summary reports

The same amendments brought in summary reports for Class II, III and IV devices. Each one is a short critical analysis of adverse effects, reported problems, incidents and serious risks, including foreign ones, over the period. It must say whether anything has changed in what's known about the device's benefits and risks.

Device classHow oftenPeriod covered
Class IIEvery two yearsThe previous 24 months
Class III and IVEvery yearThe previous 12 months

You keep summary reports on file rather than sending them in, but Health Canada can ask for them. If a report concludes that the benefits or risks have changed, you must tell Health Canada in writing within 72 hours of reaching that conclusion. Reports and the information behind them have to be kept for seven years.

Health Canada can also ask a licence holder to carry out an issue-related analysis if it has reasonable grounds to think a device may no longer meet the safety and effectiveness requirements.

What changed in 2026

Health Canada has been updating its device rules this year. Since 1 January 2026, under the agile licensing amendments, it has been able to attach terms and conditions to Class II, III and IV device licences. It also published new and revised guidance in March and April 2026, including on post-market surveillance, and changes to establishment licensing come into force on 14 December 2026. Together they point the same way: more attention on what happens to devices after they're licensed.

Where MedFortis fits

MedFortis watches recalls and safety notices from the FDA, the MHRA, Swissmedic, EUDAMED and other national regulators, as well as Health Canada, for the devices on your list. When a foreign regulator publishes something about one of your devices, it arrives in your signals inbox, ranked by severity, instead of waiting for someone to find it. Each signal is assessed by your team and the decision is recorded, which also gives you the record of foreign risks your summary reports need.

See what regulators abroad have published about your devices

Book a free 30-minute demo. We'll run MedFortis on your device lines and show you recalls and safety notices from every market you sell into.

Book a Demo →

Key takeaways

  • Class II–IV licence holders must tell Health Canada within 72 hours about risks, labelling changes, recalls and authorisation changes from listed foreign regulators.
  • The clock starts when you receive or become aware of the information, so you need a reliable way to find out.
  • Summary reports are due every two years for Class II and every year for Class III and IV, kept on file and provided on request.
  • New licence terms and conditions and updated guidance in 2026 put more weight on post-market evidence.
This article is provided for general information only and is not legal or regulatory advice. Regulatory requirements are summarised and paraphrased; always refer to the official texts and guidance, and consult a qualified regulatory professional for your specific devices and markets.